Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR)

D A Taberner, L Poller, J M Thomson, K V Darby

United Kingdom Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester.

The contribution of the thromboplastin international sensitivity index (ISI) to the interlaboratory coefficient of variation (CV) of the international normalised ratio (INR) with individual reagents was assessed. In theory the precision of the INR should increase with lower ISI values. An empirical relation has been established between the ISI, the INR, and its CV for two rabbit thromboplastins used in sufficient numbers for analysis in the United Kingdom. This was based on the cumulative data from the United Kingdom National External Quality Assessment Scheme (NEQAS) surveys over two years beginning in 1986. The actual precision achieved in NEQAS for the two reagents depends on the ISI value of the thromboplastin and it agreed closely with the figure predicted by the empirical model. The findings show that the ISI value of a thromboplastin strongly influences the interlaboratory variability of the INR obtained with it. The CV of the INR approximates to the CV of the prothrombin ratio multiplied by the ISI. Manufacturers of thromboplastin should therefore be encouraged to produce reagents showing good precision of results reported as simple prothrombin ratios and a low ISI value to avoid impairment in precision when ratio results are transformed to INR.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

ISI value of thromboplastin.

A M Van den Besselaar
J. Clin. Pathol. 1989 42: 1118-1119. [PDF]

This article has been cited by other articles:

• Lazo-Langner, A., Villa-Marquez, R., Hernandez-Hernandez, D., Rojas-Maya, S., Piedras, J. (2009). Intrahospital Correlation of the International Normalized Ratio. CLIN APPL THROMB HEMOST 15: 220-224 [Abstract]  
• Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L. (2003). American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41: 1633-1652 [Full Text]  
• Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L. (2003). American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation 107: 1692-1711 [Full Text]  
• Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., Deykin, D. (2001). Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest 119 : 8S-21S [Full Text]  
• Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B. (2000). Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests. Clin. Chem. 46: 2027-2049 [Abstract] [Full Text]  
• Strekerud, F. G., Abildgaard, U. (1998). Heparin and Low Molecular Weight Heparin Prolong Prothrombin Times in Patients on Warfarin Treatment. CLIN APPL THROMB HEMOST 4: 189-195 [Abstract]  
• Alshameeri, R., Mammen, E. F., Paisley, C., Perry, C. (1996). Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients. CLIN APPL THROMB HEMOST 2: 25-29 [Abstract]  
• Kaatz, S. S., White, R. H., Hill, J., Mascha, E., Humphries, J. E., Becker, D. M. (1995). Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations: Comparison With a Criterion Standard. Arch Intern Med 155: 1861-1867 [Abstract]  
• Schmitz, L. L., Olson, S. L., Shapiro, R. S., McCormick, S. R., Kubic, V. L. (1995). Failure to Generate Comparable International Normalized Ratio Values Using Five Different Thromboplastin Reagents in Parallel Studies of Patients Receiving Warfarin. CLIN APPL THROMB HEMOST 1: 142-150 [Abstract]